Sign inJoin waitlistJoin the waitlist

Trevor Hawkins

Director, Movement Disorders Fellowship Program · University of Colorado School of Medicine

Credentials: · · ·

History

National Ataxia Foundation Center of Excellence · University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

University of Colorado School of Medicine
2016–2018
Neurology
University of Colorado School of Medicine
2012–2015
Toledo Medical College
2008–2012

Research

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
Hepatology · 2015 · 522 citations
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients
Journal of acquired immune deficiency syndromes · 2006 · 220 citations
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults
AIDS · 2011 · 191 citations

CC
Calvin Cohen
4 papers
ED
Edwin Dejesus
4 papers
RE
Richard Elion
3 papers
BB
Brian Berman
2 papers
Christopher Gomez
2 papers
George Wilmot
2 papers
Henry Paulson
2 papers
JR
James Rooney
2 papers
JS
Jeremy Schmahmann
2 papers
Khalaf Bushara
2 papers
LR
Liana Rosenthal
2 papers
MG
Michael Geschwind
2 papers

Clinical trials

Clinical Trial Readiness for SCA1 and SCA3
Principal investigator · Unknown
The Methodist Hospital Research Institute
2018–2023
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
Site PI · Recruiting
Biogen
2024–2029